دورية أكاديمية

Molecular Advances in the Treatment of Advanced Gastrointestinal Stromal Tumor.

التفاصيل البيبلوغرافية
العنوان: Molecular Advances in the Treatment of Advanced Gastrointestinal Stromal Tumor.
المؤلفون: Venkataraman, Vinayak, George, Suzanne, Cote, Gregory M
المصدر: Oncologist; Aug2023, Vol. 28 Issue 8, p671-681, 11p, 1 Diagram, 1 Chart
مصطلحات موضوعية: GASTROINTESTINAL tumors treatment, ONLINE information services, GENETIC mutation, SYSTEMATIC reviews, MOLECULAR pathology, INVESTIGATIONAL drugs, STROMAL cells, PROTEIN-tyrosine kinase inhibitors, MEDLINE, DRUG resistance in cancer cells
مستخلص: Most gastrointestinal stromal tumors (GIST) are driven by activating mutations in Proto-oncogene c- KIT (KIT) or PDGFRA receptor tyrosine kinases (RTK). The emergence of effective therapies targeting these mutations has revolutionized the management of advanced GIST. However, following initiation of first-line imatinib, a tyrosine kinase inhibitor (TKI), nearly all patients will develop resistance within 2 years through the emergence of secondary resistance mutations in KIT , typically in the Adenosine Triphosphate (ATP)-binding site or activation loop of the kinase domain. Moreover, some patients have de novo resistance to imatinib, such as those with mutations in PDGFRA exon 18 or those without KIT or PDGFRA mutation. To target resistance, research efforts are primarily focused on developing next-generation inhibitors of KIT and/or PDGFRA, which can inhibit alternate receptor conformations or unique mutations, and compounds that impact complimentary pathogenic processes or epigenetic events. Here, we review the literature on the medical management of high-risk localized and advanced GIST and provide an update on clinical trial approaches to this disease. [ABSTRACT FROM AUTHOR]
Copyright of Oncologist is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:10837159
DOI:10.1093/oncolo/oyad167